Washington Cancer Institute at MedStar Washington Hospital — Washington D.C., District of Columbia

Washington Cancer Institute at MedStar Washington Hospital is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Washington Cancer Institute at MedStar Washington Hospital has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Giant Cell Tumor of Bone.

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington Cancer Institute at MedStar Washington Hospital?

Washington Cancer Institute at MedStar Washington Hospital has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington Cancer Institute at MedStar Washington Hospital conducted?

Washington Cancer Institute at MedStar Washington Hospital has 2 clinical trials on record, with 1 currently active. Their work covers KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Giant Cell Tumor of Bone.

Is Washington Cancer Institute at MedStar Washington Hospital accredited by Crixeo Health?

Washington Cancer Institute at MedStar Washington Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington Cancer Institute at MedStar Washington Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.